结论四物汤配方颗粒治疗无症状心肌缺血安全有效。
Conclusion: Siwu Decoction is safe and effective in asymptomatic myocardial ischemia.
目的观察通心络胶囊对冠心病无症状心肌缺血的临床疗效。
Objective To investigate the therapeutic effect of Tongxinluo on silent myocardial ischemia in patients with coronary heart disease.
目的观察加味黄连温胆汤治疗糖尿病无症状心肌缺血的临床疗效。
Objective To investigate the clinical efficacy of modified Huanglian Wendan Decoction (MHWD) on diabetic asymptomatic myocardial ischemia.
目的探讨无症状心肌缺血与心绞痛患者血浆内皮素-1变化的临床意义。
Objective To study the concentration changes and significance of endothelin(ET-1)in the patients with silent myocardial ischemia(SMI)and angina pectoris(AP).
目的：探讨参麦注射液对老年冠状动脉粥样硬化性心脏病(冠心病)无症状心肌缺血的治疗效果。
Objective: to explore the efficiency of Shenmai Injection on treating asymptomatic myocardial ischemia in senile coronary heart disease (CHD).
心电监护对防治手术病人无症状性心肌缺血及心律失常有重要临床意义。
Monitoring ECG is of importance for preventing the patients from asymptomatic cardiac ischemia and arrhythmia.
经9年的随访观察，美托洛尔可进一步减少老年无症状性心肌缺血发作的总次数和总时间，并改善患者的预后。
After 9 years of follow_up, metoprolol could reduce the total times and duration and improve the prognosis in senile patients with AMI.
从无症状性心肌缺血的中医认识、治疗观点、方药及临床病例等四个方面介绍陈镜合教授治疗本病的经验。
Prof. Chens experience on the treatment of Silent myocardial ischemia (SMI) was analysed from the aspects of TCM understanding, therapeutic viewpoint, prescription and drugs, and clinical cases.
无症状性心肌缺血的病人明显多于有症状性心肌缺血的病人（P<0.01）；
The number of patients with only asymptomatic myocardial ischemia was significantly more than that of patients with only symptomatic myocardial ischemia (P<0.01);
无症状性心肌缺血的病人明显多于有症状性心肌缺血的病人（P<0.01）；
The number of patients with only asymptomatic myocardial ischemia was significantly more than that of patients with only symptomatic myocardial ischemia (P<0.01);
应用推荐